Recent research highlights that estrogen-only hormone therapy may reduce breast cancer risk in women under 55, while combined estrogen-progestin therapy could increase risk.
A study reveals that complications during pregnancy, such as preeclampsia, gestational diabetes, and preterm birth, are linked to an increased risk of stroke years later.
Emerging research reveals heightened risk of cervical cancer in women aged 65 and older, driven by human papillomavirus (HPV). Continued screening is crucial to address increasing incidence and improve outcomes.
A large Danish study reveals that pro-inflammatory diets during pregnancy may increase the risk of type 1 diabetes in offspring, emphasizing the importance of maternal nutrition.
A clinical study reveals that trimethoprim-sulfamethoxazole does not significantly improve infant birth weight or related outcomes in HIV-positive pregnancies.
A 30-year study reveals women with endometriosis-related infertility have higher pregnancy rates compared to other infertility causes, emphasizing the importance of early diagnosis and tailored treatments.
Exploring increased pregnancy risks associated with assisted reproductive technology in kidney transplant recipients and its implications for clinical care.
New research highlights links between gut microbiota composition and gestational diabetes, offering potential for early detection and personalized treatment strategies.
Self-collection devices for cervical cancer screening offer a safe, effective, and preferred alternative to traditional methods, increasing accessibility and compliance.
Mail-in HPV self-collection kits significantly increase cervical cancer screening participation, offering a promising tool to enhance early detection and preventive care.
Recent research suggests that a 2-dose HPV vaccine regimen offers similar long-term protection against HPV-16 and HPV-18 as the 2+1-dose regimen, challenging the necessity of booster doses.
A recent study questions the specificity of USPSTF guidelines for preeclampsia risk assessment, highlighting challenges in identifying patients truly at high risk and ensuring targeted aspirin prophylaxis.
Global variations in placenta accreta spectrum (PAS) management guidelines highlight the need for improved standardization and research, especially in resource-limited settings.
A new FDA panel reignites debate over the safety and efficacy of antidepressant use during pregnancy, with experts weighing in on emerging research and practice recommendations.
Maternal depression significantly affects the quality of parenting, impairing mother-child bonding and other key behaviors. This article explores recent research, implications, and interventions.
New research highlights oxytocin's potential in reducing mood disturbances caused by sleep disruptions during hormonal transitions like postpartum and menopause.
Leading experts call on the FDA to update boxed warnings on menopausal hormone therapies, arguing current labels are outdated and deter women from effective, safe treatments.